Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Is midazolam safe for sedation in cirrhotic patients?

Ünal HÜ, Saruç M.

Turk J Gastroenterol. 2019 Jul 1. doi: 10.5152/tjg.2019.18864. [Epub ahead of print] No abstract available.

2.

Pitfalls in hypertriglyceridemia induced acute pancreatitis.

Saruç M, Ünal HÜ.

Turk J Gastroenterol. 2019 Mar;30(3):217-219. doi: 10.5152/tjg.2019.110319. No abstract available.

3.

Contrast-induced acute kidney injury/ contrast-induced nephropathy may be related to additional risk factors.

Ünal HU, Başaran Y, Akoğlu H.

Anatol J Cardiol. 2018 Feb;19(2):155. doi: 10.14744/AnatolJCardiol.2017.66915. No abstract available.

4.

The Verdict: Proton Pump Inhibitors have been found guilty of causing death. Any objections?

Ünal HÜ, Saruç M.

Turk J Gastroenterol. 2017 Nov;28(6):544-545. doi: 10.5152/tjg.2017.111017. Epub 2017 Oct 30. No abstract available.

5.

The association of profilin-1 levels with survival in chronic kidney disease.

Eroglu E, Unal HU, Guclu A, Kocyigit I, Karaman M, Saglam M, Gezer M, Tas A, Zararsiz G, Eyileten T, Aydin İ, Oguz Y, Gungor O, Yilmaz MI.

Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12839. Epub 2017 Oct 27.

PMID:
28981140
6.

IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival.

Gungor O, Unal HU, Guclu A, Gezer M, Eyileten T, Guzel FB, Altunoren O, Erken E, Oguz Y, Kocyigit I, Yilmaz MI.

PLoS One. 2017 Jun 14;12(6):e0178939. doi: 10.1371/journal.pone.0178939. eCollection 2017.

7.

Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.

Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Gezer M, Taş A, Eyileten T, Guler AK, Aydin İ, Oguz Y, Tarim K, Covic A, Yilmaz MI.

Eur J Intern Med. 2016 Sep;33:81-7. doi: 10.1016/j.ejim.2016.06.033. Epub 2016 Jul 7.

PMID:
27394925
8.

Chitotriosidase as a novel biomarker of early atherosclerosis in hemodialysis patients.

Güçlü A, Yilmaz MI, Tokmak TT, Unal HU, Karaman M, Gezer M, Taş A, Aydin İ, Akçılar R, Dursun Y.

Hemodial Int. 2017 Jan;21(1):41-46. doi: 10.1111/hdi.12451. Epub 2016 Jul 4.

PMID:
27378685
9.

Thyroid function and cardiovascular events in chronic kidney disease patients.

Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M, Gezer M, Sonmez A, Eyileten T, Aydin I, Hamcan S, Oguz Y, Covic A, Kanbay M.

J Nephrol. 2017 Apr;30(2):235-242. doi: 10.1007/s40620-016-0300-y. Epub 2016 Apr 2.

PMID:
27039198
10.

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease.

Oğuz D, Ünal HÜ, Eroğlu H, Gülmez Ö, Çevik H, Altun A.

Anatol J Cardiol. 2016 Dec;16(12):974-979. doi: 10.14744/AnatolJCardiol.2016.6706. Epub 2016 Mar 28.

11.

Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.

Yilmaz MI, Siriopol D, Saglam M, Unal HU, Karaman M, Gezer M, Kilinc A, Eyileten T, Guler AK, Aydin İ, Vural A, Oguz Y, Covic A, Ortiz A, Kanbay M.

Calcif Tissue Int. 2016 Aug;99(2):121-30. doi: 10.1007/s00223-016-0136-4. Epub 2016 Mar 26.

PMID:
27016924
12.

Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.

Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Eyileten T, Gezer M, Verim S, Oguz Y, Vural A, Ortiz A, Johnson RJ, Covic A, Yilmaz MI.

Int Urol Nephrol. 2016 Jul;48(7):1129-36. doi: 10.1007/s11255-016-1271-6. Epub 2016 Mar 23.

PMID:
27007614
13.

The Triglyceride to High-Density Lipoprotein Cholesterol Ratio Is a Useful Marker to Predict Unfavorable Cardiovascular Outcomes, But Other Confounding Factors Should Be Considered.

Ünal HU, Başaran Y, Gezer M.

J Clin Hypertens (Greenwich). 2016 Sep;18(9):951. doi: 10.1111/jch.12807. Epub 2016 Mar 8. No abstract available.

14.

The Relationship Between Plasma Whole Blood Viscosity and Cardiovascular Events in Patients With Chronic Kidney Disease.

Celik T, Yilmaz MI, Balta S, Ozturk C, Unal HU, Aparci M, Karaman M, Demir M, Yildirim AO, Saglam M, Kilic S, Eyileten T, Aydin İ, Iyisoy A.

Clin Appl Thromb Hemost. 2017 Sep;23(6):663-670. doi: 10.1177/1076029616634888. Epub 2016 Feb 22.

PMID:
26907084
15.

Ultrasonographic evaluation of the femoral cartilage thickness in patients with chronic renal failure.

Ünal HU, Tok F, Adıgüzel E, Gezer M, Aydın İ, Yılmaz B, Oğuz Y.

Ren Fail. 2016;38(4):600-4. doi: 10.3109/0886022X.2016.1149685. Epub 2016 Feb 24.

PMID:
26905953
16.

Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Siriopol D, Saglam M, Unal HU, Yaman H, Gok M, Cetinkaya H, Gaipov A, Eyileten T, Sari S, Yildirim AO, Tonbul HZ, Turk S, Covic A, Kanbay M.

Int Urol Nephrol. 2015 Dec;47(12):1993-2001. doi: 10.1007/s11255-015-1136-4. Epub 2015 Oct 26.

PMID:
26498629
17.

The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.

Sonmez A, Yilmaz MI, Saglam M, Unal HU, Gok M, Cetinkaya H, Karaman M, Haymana C, Eyileten T, Oguz Y, Vural A, Rizzo M, Toth PP.

Lipids Health Dis. 2015 Apr 16;14:29. doi: 10.1186/s12944-015-0031-4.

18.

Effects of androgen replacement therapy on cornea and tear function in men with idiopathic hypogonadotropic hypogonadism.

Gokce G, Hurmeric V, Mumcuoglu T, Ozge G, Basaran Y, Unal HU, Bolu E, Mutlu FM.

Postgrad Med. 2015 May;127(4):376-80. doi: 10.1080/00325481.2015.1033376. Epub 2015 Mar 27.

PMID:
25812631
19.

A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation.

Yilmaz MI, Sonmez A, Saglam M, Cayci T, Kilic S, Unal HU, Karaman M, Cetinkaya H, Eyileten T, Gok M, Oguz Y, Vural A, Mallamaci F, Zoccali C.

Clin J Am Soc Nephrol. 2015 Mar 6;10(3):471-9. doi: 10.2215/CJN.07860814. Epub 2014 Dec 26.

20.

Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan.

Celık T, Balta S, Karaman M, Ahmet Ay S, Demırkol S, Ozturk C, Dınc M, Unal HU, Yılmaz MI, Kılıc S, Kurt G, Tas A, Iyısoy A, Quartı-Trevano F, Fıcı F, Grassı G.

Blood Press. 2015 Feb;24(1):55-60. doi: 10.3109/08037051.2014.972816. Epub 2014 Nov 12.

PMID:
25390761
21.

Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy.

Yilmaz MI, Sonmez A, Saglam M, Kurt YG, Unal HU, Karaman M, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Vural A, Mallamaci F, Zoccali C.

Am J Nephrol. 2014;40(3):208-14. doi: 10.1159/000366169. Epub 2014 Oct 10.

22.

Mitral annular calcification and the serum osteocalcin level in patients with chronic kidney disease.

Unal HU, Çelik M, Gökoğlan Y, Çetinkaya H, Gök M, Karaman M, Yilmaz Mİ, Eyileten T, Oğuz Y.

Ren Fail. 2014 Nov;36(10):1481-5. doi: 10.3109/0886022X.2014.962421. Epub 2014 Sep 16.

PMID:
25224152
23.

Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.

Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H, Karaman M, Unal HU, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Yilmaz MI.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1854-61. doi: 10.1210/jc.2014-2042. Epub 2014 Jul 24.

PMID:
25057883
24.

Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.

Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T, Gok M, Cetinkaya H, Oguz Y, Sari S, Vural A, Mititiuc I, Covic A, Kanbay M.

Kidney Int. 2014 Dec;86(6):1213-20. doi: 10.1038/ki.2014.227. Epub 2014 Jul 2.

25.

Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events.

Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T, Saglam M, Unal HU, Gok M, Polat A, Cetinkaya H, Eyileten T, Sari S, Yildirim AO, Sonmez A, Oguz Y, Vural A, Ozen S, Carrero JJ.

Rheumatology (Oxford). 2014 Nov;53(11):2002-8. doi: 10.1093/rheumatology/keu231. Epub 2014 Jun 6.

PMID:
24907154
26.

Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.

Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, Karaman M, Oguz Y, Eyileten T, Vural A, Covic A, Goldsmith D, Turak O, Yilmaz MI.

Int Urol Nephrol. 2014 Aug;46(8):1619-25. doi: 10.1007/s11255-014-0730-1. Epub 2014 May 23.

PMID:
24853998
27.

The relationship between IL-10 levels and cardiovascular events in patients with CKD.

Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1207-16. doi: 10.2215/CJN.08660813. Epub 2014 May 1.

28.

Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Sari S, Yildirim AO, Vural A, Carrero JJ, Blanco-Colio LM.

Eur J Clin Invest. 2013 Dec;43(12):1250-7. doi: 10.1111/eci.12166. Epub 2013 Sep 20.

PMID:
24112080
29.
30.

Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Saglam M, Caglar K, Verim S, Unal HU, Gok M, Demirkaya E, Gaipov A, Kayrak M, Cetinkaya H, Eyileten T, Turk S, Vural A.

Am J Med Sci. 2014 Feb;347(2):118-24. doi: 10.1097/MAJ.0b013e3182996a96.

PMID:
23928544
31.

Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y, Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M.

Nephrology (Carlton). 2013 Nov;18(11):728-35. doi: 10.1111/nep.12130.

PMID:
23848392
32.
33.

Ongoing symptoms after eradication of Helicobacter pylori: psychiatric disorders may accompany.

Ünal HÜ, Akin E, Aydin İ, Korkmaz M, Özel S, Selçuk H, Yilmaz U.

Turk J Gastroenterol. 2013;24(1):15-21.

34.

Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C.

Am J Nephrol. 2013;37(2):126-34. doi: 10.1159/000346711. Epub 2013 Jan 31.

PMID:
23391995
35.

Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease.

Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A, Yaman H, Demirbas S, Unal HU, Gok M, Karaman M, Ay SA, Demirkaya E, Covic A, Carrero JJ.

Int Urol Nephrol. 2013 Aug;45(4):1071-8. doi: 10.1007/s11255-012-0354-2. Epub 2012 Dec 15.

PMID:
23242503
36.

Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ.

Clin Exp Nephrol. 2013 Aug;17(4):532-40. doi: 10.1007/s10157-012-0728-x. Epub 2012 Nov 20.

PMID:
23180042
37.

Serum uric acid independently predicts cardiovascular events in advanced nephropathy.

Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ.

Am J Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22.

38.

Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.

Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A.

Am J Nephrol. 2012;36(3):228-37. Epub 2012 Aug 30.

PMID:
22948239
39.

Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?

Kanbay M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T, Caglar K, Unal HU, Gok M, Vural A, Covic A.

Int Urol Nephrol. 2013 Feb;45(1):151-6. doi: 10.1007/s11255-012-0158-4. Epub 2012 Mar 23.

PMID:
22437807
40.

Findings of biopsy-proven chronicity and end-stage renal failure associated with oral sodium phosphate solution.

Cakar M, Kanbay M, Sarlak H, Akhan M, Gok M, Unal HU, Demirbas S, Yilmaz MI.

Ren Fail. 2012;34(4):499-501. doi: 10.3109/0886022X.2011.654145. Epub 2012 Jan 24.

PMID:
22268757
41.

Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.

Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1617-25. doi: 10.2215/CJN.10681210. Epub 2011 Jun 23.

Supplemental Content

Support Center